Wang Peipei, Lin Kexin, Huang Degao, Jiang Zihan, Liao Linchuan, Wang Xia
Department of Immunology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China.
Department of Forensic Toxicological Analysis, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China.
Gene. 2025 May 27;963:149595. doi: 10.1016/j.gene.2025.149595.
Lactylation, an emerging form of post-translational modification derived from lactate, plays a pivotal role in numerous cellular processes such as tumor proliferation, metabolism, inflammation, and embryonic development. However, the precise molecular mechanisms by which lactylation controls these biological functions in both physiological and pathological contexts remain elusive. This review summarizes the latest reported regulatory mechanisms of protein lactylation in various diseases since 2024, introducing the latest research progress regarding the regulatory functions of protein lactylation in pathological processes, with particular attention to the regulatory mechanisms of non-histone lactylation modification in diseases. Finally, it outlines the potential of targeted lactylation therapy, proposes the main directions for future research, and emphasizes its scientific significance for future studies.
乳酰化是一种源自乳酸的新兴翻译后修饰形式,在肿瘤增殖、代谢、炎症和胚胎发育等众多细胞过程中发挥着关键作用。然而,乳酰化在生理和病理环境中控制这些生物学功能的精确分子机制仍不清楚。本文综述了自2024年以来各种疾病中蛋白质乳酰化的最新报道调控机制,介绍了蛋白质乳酰化在病理过程中调控功能的最新研究进展,特别关注疾病中非组蛋白乳酰化修饰的调控机制。最后,概述了靶向乳酰化治疗的潜力,提出了未来研究的主要方向,并强调了其对未来研究的科学意义。